Plisulate Insulating Block No. 201

Manufacturer: Plibrico Company Product Categories: Pipe Insulation, Refractory Materials Legal Tier: Tier 2 — Litigated Product


Product Description

Plisulate Insulating Block No. 201 was a rigid thermal insulation product manufactured by the Plibrico Company, a Chicago-based firm that specialized in refractory and high-temperature industrial materials throughout much of the twentieth century. Plibrico built its reputation supplying industrial facilities — steel mills, power generation plants, chemical processing facilities, refineries, and heavy manufacturing operations — with materials engineered to withstand the extreme thermal demands of continuous industrial use.

The No. 201 designation identified a specific formulation within Plibrico’s Plisulate product line, which was designed for use in environments requiring reliable, long-term insulation performance at elevated temperatures. Insulating blocks of this type were commonly used to line furnaces, kilns, boilers, and high-temperature piping systems, as well as to insulate industrial equipment where heat retention or heat shielding was operationally critical. The block form factor made these products suitable for constructing or refurbishing thermal enclosures, wrapping large-diameter piping runs, and lining structural supports in industrial settings.

Plibrico marketed Plisulate products through direct industrial sales and distributor networks serving capital-intensive industries. The company’s materials were considered workhorses of industrial insulation, appearing in plants and facilities across the United States for decades. Like many refractory and insulation manufacturers of the mid-twentieth century, Plibrico’s product formulations during certain production periods incorporated asbestos fiber as a functional ingredient.


Asbestos Content

Plisulate Insulating Block No. 201 has been identified in litigation as an asbestos-containing product. Plaintiffs in civil litigation alleged that the No. 201 formulation contained asbestos as a component of its composition, consistent with manufacturing practices common to the refractory and industrial insulation industries during the period when asbestos was widely used as a heat-resistant reinforcing and binding material in rigid block insulation products.

Asbestos was favored in refractory and high-temperature insulation applications because of its thermal stability, tensile reinforcement properties, and resistance to chemical degradation. In rigid block insulation products of the type represented by the Plisulate line, asbestos fiber — most commonly chrysotile, though amphibole varieties were also used across the industry — was incorporated into the block matrix to enhance structural integrity and thermal performance. This made such materials extremely effective for industrial use but also created significant occupational hazard potential during installation, maintenance, and removal.

Litigation records document that Plisulate Insulating Block No. 201 was identified as a product of concern in personal injury and wrongful death actions brought by industrial workers and their survivors. The specific asbestos content percentage for this particular product formulation is not independently confirmed in publicly available regulatory documentation reviewed for this article, and precise fiber composition should be evaluated in consultation with legal and technical professionals handling individual claims.


How Workers Were Exposed

Workers who handled, installed, maintained, or removed Plisulate Insulating Block No. 201 faced the risk of asbestos fiber release at multiple points in the product’s lifecycle. Litigation records document that industrial workers in a variety of trades and job classifications encountered this product during normal work activities at facilities where Plibrico refractory and insulation materials were in use.

Installation and Construction: Workers who cut, shaped, or fitted insulating blocks to conform to the geometry of pipes, furnace walls, or equipment surfaces generated dust through sawing, grinding, breaking, and hand-trimming operations. These tasks, performed in enclosed or poorly ventilated industrial environments, could release respirable asbestos fibers into the breathing zone of workers directly performing the work and of bystanders in adjacent areas.

Maintenance and Repair: Industrial facilities routinely required maintenance on insulated systems and refractory-lined equipment. Workers conducting inspections, repairs, or modifications to areas insulated with Plisulate block products would have encountered previously installed material, often in a deteriorated or friable condition. Disturbing aged or damaged insulation block during maintenance work could release fiber concentrations equal to or greater than those generated during original installation.

Removal and Demolition: The demolition or decommissioning of industrial equipment, kilns, boilers, or pipe systems containing Plisulate Insulating Block No. 201 created high-exposure scenarios. Breaking out installed refractory and insulation block generates substantial quantities of airborne particulate, and in the absence of respiratory protection — which was frequently unavailable or inadequate during much of the product’s period of use — workers were directly exposed to released asbestos fibers.

Bystander and Secondary Exposure: Plaintiffs alleged that workers in adjacent trades — including pipefitters, boilermakers, millwrights, electricians, and general laborers working in the same industrial environments — were exposed to asbestos fibers released by insulation work performed by others nearby, without direct participation in the insulation tasks themselves.

Diseases associated with occupational asbestos exposure documented in litigation involving Plibrico products include mesothelioma, asbestos-related lung cancer, asbestosis, and other pulmonary conditions. These diseases typically present with latency periods of ten to fifty years following initial exposure, meaning that workers exposed during the mid-twentieth century may be receiving diagnoses today.


Plisulate Insulating Block No. 201 is classified as a Tier 2 litigated product for purposes of this reference. Plibrico Company has been named as a defendant in asbestos personal injury litigation, and litigation records document claims brought by workers and surviving family members alleging exposure to asbestos-containing Plibrico products including materials within the Plisulate line.

Civil Litigation: Individuals diagnosed with mesothelioma, asbestos-related lung cancer, asbestosis, or other asbestos-related diseases who have a documented work history involving exposure to Plisulate Insulating Block No. 201 or other Plibrico products may have grounds to pursue civil litigation. Plaintiffs alleged in such cases that Plibrico and related parties knew or should have known of the hazards associated with asbestos-containing products and failed to adequately warn workers of those risks.

Multi-Defendant Claims: Because industrial workers were typically exposed to products from multiple manufacturers over the course of their careers, asbestos claims frequently name multiple defendants. A thorough occupational history review conducted by an experienced asbestos attorney can identify the full range of products and manufacturers relevant to an individual’s exposure profile.

Trust Fund Claims: To the extent that other manufacturers of products used alongside Plisulate Insulating Block No. 201 have established asbestos bankruptcy trusts, affected individuals may also be eligible to file claims with those trusts in parallel with or in lieu of direct litigation. An attorney familiar with asbestos trust fund administration can evaluate eligibility across all potentially responsible parties.

Consultation: Individuals with a work history involving Plibrico Plisulate products who have received an asbestos-related diagnosis are encouraged to consult with a qualified asbestos litigation attorney. Statutes of limitations vary by state and typically begin running from the date of diagnosis rather than the date of exposure, making timely legal consultation important to preserving available remedies.


This article is provided for informational reference purposes only and does not constitute legal advice. Product identification and claim eligibility should be evaluated by qualified legal and medical professionals.